ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSK..HRIS..MTNORS..SM..................*JBDM Ver 0.1.63 (23 May 2017) - 2999001/02903616CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120180207W154deBibliographieenBibliographyfrBibliographieEP13773731.8201310042015050420160315enenen1230621420121004EP2018020720180620150812201533201712132017502017103020180207201806A61K 31/496 20060101AFI20140425BHEP A61K 31/7068 20060101ALI20140425BHEP A61P 35/00 20060101ALI20140425BHEP deVERWENDUNG VON MASITINIB IN KOMBINATION MIT GEMCITABIN ZUR BEHANDLUNG VON EINER UNTERGRUPPE DER PATIENTEN MIT BAUCHSPEICHELDRÜSENKREBSenUSE OF MASITINIB IN COMBINATION WITH GEMCITABINE FOR TREATING A SUBGROUP OF PATIENTS SUFFERING FROM PANCREATIC CANCERfrUTILISATION DU MASITINIB EN COMBINAISON AVEC LA GEMCITABINE POUR TRAITER UN SOUS-GROUPE DE PATIENTS SOUFFRANT D'UN CANCER DU PANCRÉASWO-A1-2008/115300WO-A1-2011/092338WO-A1-2012/170640WO-A2-2007/015935GANG ZHOU ET AL: "Detection and Clinical Significance of CD44v6 and Integrin-Î1 in Pancreatic Cancer Patients using a Triplex Real-Time RT-PCR Assay", APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY ; PART A: ENZYME ENGINEERING AND BIOTECHNOLOGY, HUMANA PRESS INC, NEW YORK, vol. 167, no. 8, 14 June 2012 (2012-06-14) , pages 2257-2268, XP035098339, ISSN: 1559-0291, DOI: 10.1007/S12010-012-9752-2HUMBERT MARTINE ET AL: "Masitinib combined with standard gemcitabine chemotherapy: in vitro and in vivo studies in human pancreatic tumour cell lines and ectopic mouse model", PLOS ONE, PUBLIC LIBRARY OF SCIENCE, US, vol. 5, no. 3, 1 January 2010 (2010-01-01) , pages e9430-1, XP009146696, ISSN: 1932-6203, DOI: 10.1371/JOURNAL.PONE.0009430Business Wire: "AB Science reports phase 3 study results of masitinib in combination with Gemzar® for treatment of pancreatic cancer.", , 30 October 2012 (2012-10-30), XP002718427, Retrieved from the Internet: URL:http://www.businesswire.com/news/home/ 20121030006279/en/AB-Science-reports-phase -3-study-results#.Us5dA1O198E [retrieved on 2014-01-08]G. DEPLANQUE ET AL: "A randomized, placebo-controlled phase III trial of masitinib plus gemcitabine in the treatment of advanced pancreatic cancer", ANNALS OF ONCOLOGY., vol. 26, no. 6, 9 April 2015 (2015-04-09), pages 1194-1200, XP055256745, NL ISSN: 0923-7534, DOI: 10.1093/annonc/mdv133MOUSSY, Alain22 bis passage DauphineF-75006 ParisFRKINET, Jean-Pierre62 Gleason RoadLexington, MA 02420USPIQUEMAL, David862 bis Chemin des PensionsF-30380 Saint-Christol-les-AlesFRAB Science100069920CDM-427/EP/23, avenue George V75008 ParisFRIcosa10121833783 avenue Denfert-Rochereau75014 ParisFRALATBEBGCHCYCZDEDKEEESFIFRGBGRHRHUIEISITLILTLULVMCMKMTNLNOPLPTRORSSESISKSMTREP201307074120131004enWO20140536502014041020141520150812201533